Understanding the needs and regulatory environment both in the US and abroad has become a unique strength of AGT after many years of partnering and working on large scale projects to advance human health care. The needs of the growing global population accessing modern health care systems and technology are a huge growth market. In this sector, infectious disease prevention is proving an apex challenge as the accelerated development of super virulent viruses and bacteria to which traditional methods of control are proving increasingly ineffective and subject to falling efficacy. We offer an amazing lineup of high performance solutions for this problem by providing new active ingredients that deliver unparalleled efficacy and safety to the health care community. Additionally, the nature of our technologies offer undiminished performance against newer strains of pathogens; our physical method of kill continues to work in an indiscriminate manner.
Through our technologies, we can render human skin and medical surfaces persistently antimicrobial for an extended period of time. We are able to offer this protection in many areas and formats including sanitizers and hand scrubs to implanted medical devices protected permanently from bacterial compromise in-vivo, to protection of surfaces and products used in the the most sensitive areas of Hospital facilities. We offer an new generation of technologies that deliver on superior infection protection and enhanced usability and formulation characteristics to give a whole new weapon to the fight against infection.